Vertex Pharmaceuticals ( VRTX) plunged after Q2 earnings and is now down 21% over the past year. The company has historically ...

Home appliance brand Nuuk has raised over USD 2 million (around INR 19 crore) in a follow-on funding round led by Vertex ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Vertex Pharmaceuticals will stop developing its experimental non-opioid painkiller as a solo treatment after a mid-stage ...

Vertex Pharmaceuticals beat Wall Street estimates for quarterly results on Monday, helped by demand for its new cystic ...

Vertex Pharmaceuticals said on Monday it will not continue development of its experimental non-opioid painkiller as a solo ...

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators ...

The experimental drug is similar to the Boston-based company’s recently approved pill Journavx but could potentially be given ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Patient advocacy groups are urging the South African government to reopen an antitrust investigation into Vertex ...

Vertex reported quarterly earnings of 15 cents per share which beat the analyst consensus estimate of 14 cents per share. The ...

Vertex Inc. (NASDAQ:VERX) is one of the worst-performing stocks on Wednesday. Vertex fell to a new 52-week low on Wednesday ...